Member Info for francobrett

yes I can't imagine why one would sell on news of a distribution agreement but let's see

This is the important bit: EnvoyAI assists research institutions and emerging AI companies in the translation and commercialisation processes, starting with rapid deployment via a scalable, secure, cloud-based infrastructure with the ability to add local components to facilitate on-site deployments as well. EnvoyAI also works with distribution partners to make algorithms on the platform available to a very wide footprint of hospitals and, ultimately, to physicians. I'm assuming that when Stonechecker gets FDA it will be added by EnvoyAI as well and can be rolled out with immediate effect. Looking good here and there's been plenty of opportunity to get in low GLA

And JKOK is retired but too busy to go to an investor evening, hmmm.

Medical imaging software is the future and FBDU have just acquired Imaging Biometrics, a tactical and strategic move with a company that has an FDA approved product. This was seen as preferential to going alone. FBDU hope to be at the forefront of this groundbreaking meditech. Agreement also signed with South Korea. Tiny mcap..just to summarise.

We were promised sales Q1 however things have changed tactically and the distribution is happening differently and in a vastly preferable way imo. People may not understand this and the mms will take advantage. I will be looking to lower my average here GLA

Correspondingly the more collaborations entered into the greater the chance of something meaningful coming out of it. It may take a while but the ball is rolling. Meanwhile the shorters still have the opportunity to snipe at NR. I just hate how gleefully they do it.

They mention names when they are allowed. The bigger companies insist on NDAs

some are FF! Yet more good news with the high end collaborations. So many now that this can be ignored. Shame about the typos or is Neil laughing when he talks of enhahenced?

BRH own 38% of Kirkstall. This is massively undervalued IMO

up 31%

Everything seems to be falling into place. IMO news of first sales, promised in Q1, is the trigger the market is waiting for. Agree with Gustos that the possibility of a cash purchase does suggest confidence in sales.

IB have been managing the CE marking and FDA clearance process for StoneChecker� software, Flying Brands' own software product, and FDA clearance is expected by the end of Q2 2018. The launch of StoneChecker in the USA will include targeting of the existing luminary sites which IB have established for their IB Clinic product, and marketing resources will be combined to target the same customer group of Board-certified Radiologists at both tertiary and regional hospitals. Looks like it's ready to go. Massive US market

Lots of tiny trades on all stocks delayed this morning giving the impression of no volume

AIM is like a ghost town this morning. No volume anywhere. People being cautious?

A new MM has appeared on this for what it's worth

and paying over for 10k hmm

on no trades

Someone bought some Nektan!

Ffwd have done the paperwork. It�s barclay�s problem

A taste of your own medicine I'm afraid Persimmon. Apologies to other Thru holders but this guy has behaved very badly over on RBD on a daily basis.